See You Later Frown Lines & WrinklesXeomin Cosmetic
Soften Wrinkles Through Muscle Relaxation
Xeomin (incobotulinumtoxinA), is approved by the US FDA for the treatment of adults with cervical dystonia or blepharospasm. Botulinum toxin blocks nerve activity in the muscles, causing a temporary reduction in muscle activity.
Xeomin is FDA approved and can be used to treat the same facial lines treated by Botox and Dysport, including frown lines, crow’s feet and forehead wrinkles.
Worldwide, more than 84,000 people have been treated with Xeomin injections. The U.S. is actually the 20th country to approve this new drug.
Better or worse then Botox?
Xeomin has no additives, just botulinum toxin type A. This may mean that there is less risk of developing antibodies against Xeomin than other available neurotoxins. The body develops antibodies in response to a foreign invader and attacks. In theory, antibodies could prevent a neurotoxin from having its desired effects. The effects of Xeomin occur within one week, and the results last from three to six months, making it comparable to Botox in terms of both onset and duration of action. Xeomin should not be used interchangeably with other botulinum products.
Before & After Pictures for Xeomin
What are the risks?
There is a risk that all botulinum toxin products may spread from the area where they were injected to other parts of the body, causing potentially life-threatening swallowing and breathing problems. This was predominantly seen in children treated with Botox off-label for cerebral palsy. These issues have not been reported among people who received botulinum products for cosmetic uses or to treat blepharospasm.
Other risks may include bleeding and bruising at the injection site and allergic reactions such as itching, swelling or shortness of breath.
Ready To Improve The Way You Look?
Call EARLMD Today to book the next available NO-Obligation Consultation
at (479) 273-1426 or click below to submit your request online.
Dr. Earl can treat almost every part of you body using the latest technology.